Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

Status:
Completed

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

Study designed to evaluate the safety and efficacy of MTS compared to placebo with reference to CONCERTA® in pediatric subjects diagnosed with ADHD.

Phase 3

Noven Therapeutics

Methylphenidate